Eva Nievergall

1.6k citations
17 papers · 859 indexed · h-index 10
Topics
Axon Guidance and Neuronal Signaling (8 papers)Chronic Myeloid Leukemia Treatments (8 papers)Chronic Lymphocytic Leukemia Research (7 papers)

In The Last Decade

Eva Nievergall

16 papers receiving 852 citations

Peers

Eva Nievergall
Comparison fields: 5 of 66
  • Molecular Biology 479
  • Cellular and Molecular Neuroscience 420
  • Cell Biology 252
  • Oncology 176
  • Hematology 106
Replace Beatrix Böhme with:
Beatrix Böhme Germany
Francesca Caccavari Italy
Ze’ev Gechtman Israel
Chana Weiss Israel
Uwe Schlomann Germany
David J. Easty United Kingdom
Paolo Conrotto Sweden
Sílvia Coma United States
Ute Zacharias Germany
Christian Beaudry United States
Eva Nievergall relative to Beatrix Böhme Germany Beatrix Böhme's profile →
Citations per field
00.5×4.8×
Beatrix Böhme · 1×
Citations per year

Countries citing papers authored by Eva Nievergall

Since Specialization
Citations

This map shows the geographic impact of Eva Nievergall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Nievergall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Nievergall more than expected).

Fields of papers citing papers by Eva Nievergall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Nievergall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Nievergall. The network helps show where Eva Nievergall may publish in the future.

Co-authorship network of co-authors of Eva Nievergall

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Nievergall. A scholar is included among the top collaborators of Eva Nievergall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Nievergall. Eva Nievergall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 2
2 38
3 9
4 25
5 0
6 79
7 9
8 76
9 9
10 3
11 1
12 75
13 80
14 1
15 55
16 46
17 351

About Eva Nievergall

Eva Nievergall is a scholar working on Hematology, Genetics and Cellular and Molecular Neuroscience, having authored 17 papers that have together received 859 indexed citations. Recurring topics across this work include Axon Guidance and Neuronal Signaling (8 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (420 citations), Immunology and Allergy (103 citations) and Cell Biology (252 citations). Eva Nievergall has collaborated with scholars based in Australia, Germany and United States. Frequent co-authors include Martin Lackmann, Peter W. Janes, Sabine Wimmer-Kleikamp, Dimitar B. Nikolov, William A. Barton, Momchil V. Kolev, Nayanendu Saha, Juha‐Pekka Himanen, Carl Blobel and Timothy P. Hughes. Their work appears in journals such as Cell, The Journal of Cell Biology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026